Public issuer activity

Ryvu Therapeutics S.A.

Listed company

stockanalysis_wse_issuer_list-5da8be237225

1 recent public procurement event linked to Ryvu Therapeutics S.A.

DemandTrace links public procurement activity to listed companies so you can inspect what became knowable and why.

Recent events: 1
Latest publicly knowable: 25 Aug 2026
Currencies: PLN
Issuer-to-company relationship: Medium confidence

Observed awards

Awarded public contracts

Ryvu Therapeutics S.A.: 1 public procurement contract in the currently observed record (publicly knowable from 25 Aug 2026 to 25 Aug 2026).

Recent awarded contracts

ZP/CZD/062/26 Dostawa badanego produktu leczniczego ROMACICLIB (RVU 120) do zastosowania w ramach niekomercyjnego badania klinicznego MEDWAY „Badanie fazy I dotyczące stosowania inhibitora CDK8 RVU120 w połączeniu z ewerolimusem u dzieci z nawracającym lub postępującym medulloblastoma grupy 3 lub 4"Publicly knowable 25 Aug 2026 · Instytut "Pomnik-Centrum Zdrowia Dziecka" → Ryvu Therapeutics S.A. · PLN 1,732,782.91 (final award value)
Award page View evidence View source

Full event records (all fields, on demand)

Publicly knowable 25 Aug 2026

Public procurement record

Awarded

ZP/CZD/062/26 Dostawa badanego produktu leczniczego ROMACICLIB (RVU 120) do zastosowania w ramach niekomercyjnego badania klinicznego MEDWAY „Badanie fazy I dotyczące stosowania inhibitora CDK8 RVU120 w połączeniu z ewerolimusem u dzieci z nawracającym lub postępującym medulloblastoma grupy 3 lub 4"

Amount: PLN 1,732,782.91 (final award value) Official value of the awarded result.
Buyer: Instytut "Pomnik-Centrum Zdrowia Dziecka"
Supplier: Ryvu Therapeutics S.A.
Procurement subject: Przedmiotem zamówienia jest dostawa badanego produktu leczniczego ROMACICLIB (RVU 120) do zastosowania w ramach niekomercyjnego badania klinicznego MEDWAY „Badanie fazy I dotyczące stosowania inhibitora CDK8 RVU120 w połączeniu z ewerolimusem u dzieci z nawracającym lub postępującym medulloblastoma grupy 3 lub 4" RVU120 kapsułki 25 mg, 30 kapsułek w butelce RVU120 kapsułki 100 mg, 30 kapsułek w butelce
CPV category: 33600000
Source: Public procurement record
Published: 25 Aug 2026

View source View evidence Award page

How this was verified

Buyers in this record

Instytut "Pomnik-Centrum Zdrowia Dziecka" (1)

Suppliers named in sources

Ryvu Therapeutics S.A. (1)

CPV categories

33600000 (1)

The number in parentheses is how many awarded events in this record mention the entry. Names are reproduced exactly as recorded; similar names are not merged.

Counts describe the currently observed public corpus, not the whole market. Amounts, when shown, are the disclosed headline value of the individual contract. Source coverage and the supplier-to-issuer group mapping are explained in the sections below.

Why this company

One issuer relationship, stated once

DemandTrace links this public procurement activity to Ryvu Therapeutics S.A. on the issuer-to-company axis. This assertion is separate from the supplier-mapping count shown below.

Issuer-to-company relationship: Medium confidence
Supplier-mapping count: 1
Evidence floor: 0

Show supporting evidence

No supporting public references are included in the current record.

Important caveats

The issuer-link assessment includes an additional evidence caveat.
The issuer-link assessment includes an additional evidence caveat.
Only one matching candidate was identified; alternatives could not be cross-validated.

This explains the issuer relationship; it does not change the procurement event itself.

Activity history

This history shows lifecycle moments present in the public event record. It does not add details that are absent from the source.

AwardedPublic state
Recorded date: 25 Aug 2026

Keep track of new activity

What is new since I last looked?

Choose a date to see whether additional public procurement events were surfaced after your last check.

Compare with a date you last checked to see whether new public procurement events were added.

Choose a date to see the newly surfaced events and the change in count.

How DemandTrace verified this activity

DemandTrace uses publicly available procurement records and keeps a traceable evidence bundle for each surfaced event. The date shown above is when the public record was knowable, not an internal processing timestamp.

Each surfaced event shows the buyer, supplier, procurement subject, CPV category and source link when the underlying public record includes them. Fields missing from a record stay undisclosed rather than inferred.

This is validation-stage public-record evidence for research purposes. It is not investment advice, investment research, or a recommendation to buy or sell anything.